Late Adverse Events after Enhanced and Unenhanced MRI and CT: A Prospective Study

Prospective evaluation of frequency of late and very late adverse events in patients undergoing enhanced or unenhanced magnetic resonance imaging (MRI) or computed tomography (CT). The imaging procedure was performed according to the protocols of the department. All patients were contacted 3 days af...

Full description

Saved in:
Bibliographic Details
Published inBasic & clinical pharmacology & toxicology Vol. 114; no. 5; pp. 427 - 435
Main Authors Azzouz, Manal, Rømsing, Janne, Thomsen, Henrik S.
Format Journal Article
LanguageEnglish
Published Oxford Blackwell 01.05.2014
Wiley Subscription Services, Inc
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Prospective evaluation of frequency of late and very late adverse events in patients undergoing enhanced or unenhanced magnetic resonance imaging (MRI) or computed tomography (CT). The imaging procedure was performed according to the protocols of the department. All patients were contacted 3 days after their imaging procedure for the occurrence of late adverse events (LAEs) and a month later for the occurrence of very late adverse events (VLAEs) using a structured questionnaire. A total of 1042 (71%) among 1473 patients completed both the 3‐day and 1‐month questionnaire. The incidence of LAEs was significantly higher in the enhanced MRI (38%) and CT (27%) groups than unenhanced MRI (20%) and CT (16%) groups. The frequency of nausea, dizziness, abdominal pain and diarrhoea was significantly higher in the enhanced MRI group than in the MRI control group, while taste sensation was reported more frequent in the enhanced CT group than in the CT control group. The incidence of VLAEs was significantly higher in the enhanced CT (21%) than unenhanced CT group (13%). The same LAEs and VLAEs were reported in all four groups. LAEs and VLAEs were reported more often in patients with allergy in both the enhanced and unenhanced groups. The incidence of LAEs and VLAEs was higher in the enhanced groups than in the unenhanced groups. The most reported adverse events in the enhanced groups were also reported in the unenhanced groups. Patients with allergy reported LAE and VLAE more often. This suggests that adverse events may not always be caused by the contrast media.
AbstractList Prospective evaluation of frequency of late and very late adverse events in patients undergoing enhanced or unenhanced magnetic resonance imaging (MRI) or computed tomography (CT). The imaging procedure was performed according to the protocols of the department. All patients were contacted 3 days after their imaging procedure for the occurrence of late adverse events (LAEs) and a month later for the occurrence of very late adverse events (VLAEs) using a structured questionnaire. A total of 1042 (71%) among 1473 patients completed both the 3-day and 1-month questionnaire. The incidence of LAEs was significantly higher in the enhanced MRI (38%) and CT (27%) groups than unenhanced MRI (20%) and CT (16%) groups. The frequency of nausea, dizziness, abdominal pain and diarrhoea was significantly higher in the enhanced MRI group than in the MRI control group, while taste sensation was reported more frequent in the enhanced CT group than in the CT control group. The incidence of VLAEs was significantly higher in the enhanced CT (21%) than unenhanced CT group (13%). The same LAEs and VLAEs were reported in all four groups. LAEs and VLAEs were reported more often in patients with allergy in both the enhanced and unenhanced groups. The incidence of LAEs and VLAEs was higher in the enhanced groups than in the unenhanced groups. The most reported adverse events in the enhanced groups were also reported in the unenhanced groups. Patients with allergy reported LAE and VLAE more often. This suggests that adverse events may not always be caused by the contrast media.
Abstract Prospective evaluation of frequency of late and very late adverse events in patients undergoing enhanced or unenhanced magnetic resonance imaging ( MRI ) or computed tomography ( CT ). The imaging procedure was performed according to the protocols of the department. All patients were contacted 3 days after their imaging procedure for the occurrence of late adverse events ( LAE s) and a month later for the occurrence of very late adverse events ( VLAE s) using a structured questionnaire. A total of 1042 (71%) among 1473 patients completed both the 3‐day and 1‐month questionnaire. The incidence of LAE s was significantly higher in the enhanced MRI (38%) and CT (27%) groups than unenhanced MRI (20%) and CT (16%) groups. The frequency of nausea, dizziness, abdominal pain and diarrhoea was significantly higher in the enhanced MRI group than in the MRI control group, while taste sensation was reported more frequent in the enhanced CT group than in the CT control group. The incidence of VLAE s was significantly higher in the enhanced CT (21%) than unenhanced CT group (13%). The same LAE s and VLAE s were reported in all four groups. LAE s and VLAE s were reported more often in patients with allergy in both the enhanced and unenhanced groups. The incidence of LAE s and VLAE s was higher in the enhanced groups than in the unenhanced groups. The most reported adverse events in the enhanced groups were also reported in the unenhanced groups. Patients with allergy reported LAE and VLAE more often. This suggests that adverse events may not always be caused by the contrast media.
Prospective evaluation of frequency of late and very late adverse events in patients undergoing enhanced or unenhanced magnetic resonance imaging (MRI) or computed tomography (CT). The imaging procedure was performed according to the protocols of the department. All patients were contacted 3 days after their imaging procedure for the occurrence of late adverse events (LAEs) and a month later for the occurrence of very late adverse events (VLAEs) using a structured questionnaire. A total of 1042 (71%) among 1473 patients completed both the 3-day and 1-month questionnaire. The incidence of LAEs was significantly higher in the enhanced MRI (38%) and CT (27%) groups than unenhanced MRI (20%) and CT (16%) groups. The frequency of nausea, dizziness, abdominal pain and diarrhoea was significantly higher in the enhanced MRI group than in the MRI control group, while taste sensation was reported more frequent in the enhanced CT group than in the CT control group. The incidence of VLAEs was significantly higher in the enhanced CT (21%) than unenhanced CT group (13%). The same LAEs and VLAEs were reported in all four groups. LAEs and VLAEs were reported more often in patients with allergy in both the enhanced and unenhanced groups. The incidence of LAEs and VLAEs was higher in the enhanced groups than in the unenhanced groups. The most reported adverse events in the enhanced groups were also reported in the unenhanced groups. Patients with allergy reported LAE and VLAE more often. This suggests that adverse events may not always be caused by the contrast media. [PUBLICATION ABSTRACT]
Prospective evaluation of frequency of late and very late adverse events in patients undergoing enhanced or unenhanced magnetic resonance imaging (MRI) or computed tomography (CT). The imaging procedure was performed according to the protocols of the department. All patients were contacted 3 days after their imaging procedure for the occurrence of late adverse events (LAEs) and a month later for the occurrence of very late adverse events (VLAEs) using a structured questionnaire. A total of 1042 (71%) among 1473 patients completed both the 3-day and 1-month questionnaire. The incidence of LAEs was significantly higher in the enhanced MRI (38%) and CT (27%) groups than unenhanced MRI (20%) and CT (16%) groups. The frequency of nausea, dizziness, abdominal pain and diarrhoea was significantly higher in the enhanced MRI group than in the MRI control group, while taste sensation was reported more frequent in the enhanced CT group than in the CT control group. The incidence of VLAEs was significantly higher in the enhanced CT (21%) than unenhanced CT group (13%). The same LAEs and VLAEs were reported in all four groups. LAEs and VLAEs were reported more often in patients with allergy in both the enhanced and unenhanced groups. The incidence of LAEs and VLAEs was higher in the enhanced groups than in the unenhanced groups. The most reported adverse events in the enhanced groups were also reported in the unenhanced groups. Patients with allergy reported LAE and VLAE more often. This suggests that adverse events may not always be caused by the contrast media.
Author Rømsing, Janne
Azzouz, Manal
Thomsen, Henrik S.
Author_xml – sequence: 1
  givenname: Manal
  surname: Azzouz
  fullname: Azzouz, Manal
  organization: Copenhagen University Hospital Herlev
– sequence: 2
  givenname: Janne
  surname: Rømsing
  fullname: Rømsing, Janne
  organization: University of Copenhagen
– sequence: 3
  givenname: Henrik S.
  surname: Thomsen
  fullname: Thomsen, Henrik S.
  organization: University of Copenhagen
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=28361805$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/24238213$$D View this record in MEDLINE/PubMed
BookMark eNp9kF1P2zAUhi1URMvHDT8AWZomTZMKPraTuLsrVQdIncZGuY4c-0RLlTrFTor67-fSAhIX-MY-x4_eYz_HpOcah4ScA7uEuK4Ks2ovgUOWHJABZJIPMyVF7-0skj45DmHBGM8ksCPS55ILxUEMyJ-ZbpGO7Rp9QDpdo2sD1WWLnk7dP-0MWqqdpY8OX8tff-9eWpP5Dzqm974JKzRttUb60HZ2c0oOS10HPNvvJ-Tx53Q-uR3Oft_cTcazoZFJmgxTw43NeKqZtiZVUsoMpCl5qVgKoGwhuBhBCUaiUpYVGuN9oWKj5GnBrDgh33a5K988dRjafFkFg3WtHTZdyCHhTCimsiSiXz6gi6bzLr4uUiAEjCAbRer7jjLxS8Fjma98tdR-kwPLt6Lzrej8RXSEL_aRXbFE-4a-mo3A1z2gg9F16aO8KrxzSqSg2DYIdtxzVePmk5H59eR-vhv-H3OElA8
CitedBy_id crossref_primary_10_5863_1551_6776_24_6_534
crossref_primary_10_1097_RLI_0000000000000528
Cites_doi 10.1007/s00330-002-1339-9
10.1007/s00330-002-1650-5
10.1148/radiol.2393050560
10.1111/j.1600-0773.1997.tb00292.x
10.1007/s003300000729
10.4236/ojcd.2013.33016
10.1080/02841859209173196
10.1148/radiol.10091848
10.1016/j.ejrad.2010.12.104
10.1016/j.ejrad.2008.01.023
10.1067/mhj.2001.113570
10.1097/00004424-199801000-00001
10.1007/s00330-011-2200-9
10.1177/028418519503600113
ContentType Journal Article
Copyright 2013 Nordic Association for the Publication of BCPT (former Nordic Pharmacological Society)
2015 INIST-CNRS
2013 Nordic Association for the Publication of BCPT (former Nordic Pharmacological Society).
Copyright © 2014 Nordic Association for the Publication of BCPT (former Nordic Pharmacological Society)
Copyright_xml – notice: 2013 Nordic Association for the Publication of BCPT (former Nordic Pharmacological Society)
– notice: 2015 INIST-CNRS
– notice: 2013 Nordic Association for the Publication of BCPT (former Nordic Pharmacological Society).
– notice: Copyright © 2014 Nordic Association for the Publication of BCPT (former Nordic Pharmacological Society)
DBID IQODW
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7QP
7TK
7U7
C1K
DOI 10.1111/bcpt.12175
DatabaseName Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
Calcium & Calcified Tissue Abstracts
Neurosciences Abstracts
Toxicology Abstracts
Environmental Sciences and Pollution Management
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
Toxicology Abstracts
Calcium & Calcified Tissue Abstracts
Neurosciences Abstracts
Environmental Sciences and Pollution Management
DatabaseTitleList Toxicology Abstracts
CrossRef
Toxicology Abstracts
MEDLINE

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Pharmacy, Therapeutics, & Pharmacology
EISSN 1742-7843
EndPage 435
ExternalDocumentID 3268493101
10_1111_bcpt_12175
24238213
28361805
BCPT12175
Genre article
Research Support, Non-U.S. Gov't
Journal Article
Comparative Study
GrantInformation_xml – fundername: Johannes Fogs Fond
– fundername: Aase og Ejnar Danielsens Fond
GroupedDBID ---
.3N
.GA
.GJ
.Y3
05W
0R~
10A
1OC
23N
24P
31~
33P
36B
3O-
3SF
4.4
50Y
50Z
51W
51X
52M
52N
52O
52P
52R
52S
52T
52U
52V
52W
52X
53G
5HH
5LA
5RE
5VS
66C
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A01
A03
AAESR
AAEVG
AAHHS
AANLZ
AAONW
AASGY
AAXRX
AAYOK
AAZKR
ABCQN
ABCUV
ABDBF
ABEML
ABJNI
ABPVW
ABQWH
ABXGK
ACAHQ
ACCFJ
ACCZN
ACGFS
ACGOF
ACMXC
ACPOU
ACPRK
ACSCC
ACXBN
ACXQS
ADBBV
ADBTR
ADEOM
ADIZJ
ADKYN
ADMGS
ADOZA
ADXAS
ADZMN
ADZOD
AEEZP
AEIGN
AEIMD
AENEX
AEQDE
AEUQT
AEUYR
AFBPY
AFEBI
AFFPM
AFGKR
AFPWT
AFRAH
AFZJQ
AHBTC
AIACR
AITYG
AIURR
AIWBW
AJBDE
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
AMBMR
AMYDB
ATUGU
AZBYB
AZVAB
BAFTC
BFHJK
BHBCM
BMXJE
BROTX
BRXPI
BY8
C45
CAG
COF
CS3
D-6
D-7
D-E
D-F
DCZOG
DPXWK
DR2
DRFUL
DRMAN
DRSTM
DU5
EAD
EAP
EBC
EBD
EBS
EDH
EJD
EMB
EMK
EMOBN
EST
ESX
EX3
F00
F01
F04
F5P
FUBAC
G-S
G.N
GODZA
H.X
HF~
HGLYW
HZI
HZ~
IHE
IX1
J0M
KBYEO
L7B
LATKE
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LSO
LUTES
LW6
LYRES
MEWTI
MK0
MK4
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
N04
N05
N9A
NF~
O66
O9-
OIG
OK1
OVD
P2W
P2X
P2Z
P4B
P4D
Q.N
Q11
QB0
R.K
RJQFR
ROL
RX1
SUPJJ
SV3
TEORI
TUS
UB1
W8V
W99
WBKPD
WHWMO
WIH
WIJ
WIK
WOHZO
WOW
WQJ
WRC
WVDHM
WXI
WXSBR
XG1
YCJ
~IA
~WT
08R
AAVGM
ABHUG
ABPTK
ACXME
ADAWD
ADDAD
AFVGU
AGJLS
IPNFZ
IQODW
WIN
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7QP
7TK
7U7
C1K
ID FETCH-LOGICAL-c4565-6c2cd726a0adc68444714cf2f806118db32391f1c4e88d0bae714b8f1cf26b0d3
IEDL.DBID DR2
ISSN 1742-7835
IngestDate Sat Aug 17 02:52:01 EDT 2024
Thu Oct 10 22:07:11 EDT 2024
Fri Aug 23 03:31:57 EDT 2024
Sat Sep 28 07:54:37 EDT 2024
Tue Sep 20 21:44:48 EDT 2022
Sat Aug 24 01:08:38 EDT 2024
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 5
Keywords Human
Prospective
Late
Radiodiagnosis
Toxicity
Secondary effect
Medical imagery
Exploration
Computerized axial tomography
Nuclear magnetic resonance imaging
Contrast media
Language English
License CC BY 4.0
2013 Nordic Association for the Publication of BCPT (former Nordic Pharmacological Society).
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c4565-6c2cd726a0adc68444714cf2f806118db32391f1c4e88d0bae714b8f1cf26b0d3
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
OpenAccessLink https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/bcpt.12175
PMID 24238213
PQID 1513319179
PQPubID 1026375
PageCount 9
ParticipantIDs proquest_miscellaneous_1520380875
proquest_journals_1513319179
crossref_primary_10_1111_bcpt_12175
pubmed_primary_24238213
pascalfrancis_primary_28361805
wiley_primary_10_1111_bcpt_12175_BCPT12175
PublicationCentury 2000
PublicationDate May 2014
PublicationDateYYYYMMDD 2014-05-01
PublicationDate_xml – month: 05
  year: 2014
  text: May 2014
PublicationDecade 2010
PublicationPlace Oxford
PublicationPlace_xml – name: Oxford
– name: England
PublicationTitle Basic & clinical pharmacology & toxicology
PublicationTitleAlternate Basic Clin Pharmacol Toxicol
PublicationYear 2014
Publisher Blackwell
Wiley Subscription Services, Inc
Publisher_xml – name: Blackwell
– name: Wiley Subscription Services, Inc
References 1997; 80
1998; 39
2000; 18
2013; 3
2001; 141
2011; 80
1995; 36
2010; 255
2006; 240
2003; 13
2003; 15
2011; 21
2008; 66
2001; 11
1992; 33
1998; 33
1996; 6
1990; 50
Higashi TS (e_1_2_6_11_1) 1990; 50
Munechika H (e_1_2_6_10_1) 2003; 13
e_1_2_6_20_1
Schild H (e_1_2_6_19_1) 1996; 6
Yasuda R (e_1_2_6_2_1) 1998; 33
e_1_2_6_8_1
Hosoya T (e_1_2_6_9_1) 2000; 18
Sutton AGC (e_1_2_6_18_1) 2003; 15
e_1_2_6_5_1
e_1_2_6_4_1
e_1_2_6_7_1
e_1_2_6_6_1
e_1_2_6_13_1
e_1_2_6_14_1
e_1_2_6_3_1
Rydberg J (e_1_2_6_17_1) 1998; 39
e_1_2_6_12_1
e_1_2_6_15_1
e_1_2_6_16_1
References_xml – volume: 50
  start-page: 1359
  year: 1990
  end-page: 1366
  article-title: The delayed adverse reactions of low osmolar contrast media
  publication-title: Nihon Igaku Hoshasen Gakkai Zasshi
– volume: 141
  start-page: 677
  year: 2001
  end-page: 683
  article-title: Early and late reactions after the use of iopamidol 340, ioxaglate 320, and iodixanol 320 in cardiac catheterization
  publication-title: Am Heart J
– volume: 11
  start-page: 1267
  year: 2001
  end-page: 1275
  article-title: Adverse reactions to iodinated contrast media
  publication-title: Eur Radiol
– volume: 39
  start-page: 219
  year: 1998
  end-page: 222
  article-title: Frequency of late allergy‐like adverse reactions following injection of intravascular non‐ionic contrast media. A retrospective study comparing a non‐ionic monomeric contrast medium with a non‐ionic dimeric contrast medium
  publication-title: Acta Radiol
– volume: 33
  start-page: 1
  year: 1998
  end-page: 5
  article-title: Delayed adverse reactions to non‐ionic monomeric contrast‐enhanced media
  publication-title: Invest Radiol
– volume: 3
  start-page: 85
  year: 2013
  end-page: 93
  article-title: Acute non‐renal adverse events after unenhanced and enhanced computed tomography and magnetic resonance imaging
  publication-title: Open J Clin Diagn
– volume: 18
  start-page: 39
  year: 2000
  end-page: 45
  article-title: Delayed adverse reactions to iodinated contrast media and their risk factors
  publication-title: Radiat Med
– volume: 33
  start-page: 368
  year: 1992
  end-page: 373
  article-title: Iopentol in urography. A clinical comparison between iopentol and metrizoate including delayed reactions
  publication-title: Acta Radiol
– volume: 80
  start-page: 108
  year: 1997
  end-page: 110
  article-title: Frequency of acute adverse events to a non‐ionic low‐osmolar contrast medium: the effect of verbal interview
  publication-title: Pharmacol Toxicol
– volume: 255
  start-page: 764
  year: 2010
  end-page: 771
  article-title: Delayed adverse reaction to contrast‐enhanced CT: a prospective single‐center study comparison to control group without enhancement
  publication-title: Radiology
– volume: 15
  start-page: 133
  year: 2003
  end-page: 138
  article-title: Early and late reactions following the use of iopamidol 340, iomeprol 350 and iodixanol 320 in cardiac catheterization
  publication-title: J Invasive Cardiol
– volume: 36
  start-page: 72
  year: 1995
  end-page: 76
  article-title: Acute and late adverse reactions to low‐osmolal contrast media
  publication-title: Acta Radiol
– volume: 240
  start-page: 56
  year: 2006
  end-page: 64
  article-title: Adverse events after unenhanced and monomeric and dimeric contrast‐enhanced CT: a prospective randomized controlled trial
  publication-title: Radiology
– volume: 13
  start-page: 185
  year: 2003
  end-page: 194
  article-title: A prospective survey of delayed adverse reactions to iohexol in urography and computed tomography
  publication-title: Eur Radiol
– volume: 80
  start-page: 77
  year: 2011
  end-page: 82
  article-title: Contrast media safety‐an update
  publication-title: Eur J Radiol
– volume: 21
  start-page: 2305
  year: 2011
  end-page: 2310
  article-title: Contrast Media Safety Committee of European Society of Urogenital Radiology (ESUR). Late adverse reactions to intravascular iodine based contrast media: an update
  publication-title: Eur Radiol
– volume: 13
  start-page: 181
  year: 2003
  end-page: 184
  article-title: Late adverse reactions to intravascular iodinated contrast media
  publication-title: Eur Radiol
– volume: 6
  start-page: 9
  year: 1996
  end-page: 10
  article-title: Delayed allergy‐like reactions in patients: monomeric and dimeric contrast media compared with plain CT
  publication-title: Eur Radiol
– volume: 66
  start-page: 160
  year: 2008
  end-page: 167
  article-title: Extracellular gadolinium‐based contrast media: an overview
  publication-title: Eur J Radiol
– volume: 13
  start-page: 185
  year: 2003
  ident: e_1_2_6_10_1
  article-title: A prospective survey of delayed adverse reactions to iohexol in urography and computed tomography
  publication-title: Eur Radiol
  doi: 10.1007/s00330-002-1339-9
  contributor:
    fullname: Munechika H
– ident: e_1_2_6_15_1
  doi: 10.1007/s00330-002-1650-5
– volume: 15
  start-page: 133
  year: 2003
  ident: e_1_2_6_18_1
  article-title: Early and late reactions following the use of iopamidol 340, iomeprol 350 and iodixanol 320 in cardiac catheterization
  publication-title: J Invasive Cardiol
  contributor:
    fullname: Sutton AGC
– ident: e_1_2_6_6_1
  doi: 10.1148/radiol.2393050560
– volume: 18
  start-page: 39
  year: 2000
  ident: e_1_2_6_9_1
  article-title: Delayed adverse reactions to iodinated contrast media and their risk factors
  publication-title: Radiat Med
  contributor:
    fullname: Hosoya T
– ident: e_1_2_6_13_1
  doi: 10.1111/j.1600-0773.1997.tb00292.x
– ident: e_1_2_6_16_1
  doi: 10.1007/s003300000729
– ident: e_1_2_6_14_1
  doi: 10.4236/ojcd.2013.33016
– ident: e_1_2_6_12_1
  doi: 10.1080/02841859209173196
– ident: e_1_2_6_5_1
  doi: 10.1148/radiol.10091848
– volume: 50
  start-page: 1359
  year: 1990
  ident: e_1_2_6_11_1
  article-title: The delayed adverse reactions of low osmolar contrast media
  publication-title: Nihon Igaku Hoshasen Gakkai Zasshi
  contributor:
    fullname: Higashi TS
– ident: e_1_2_6_3_1
  doi: 10.1016/j.ejrad.2010.12.104
– volume: 39
  start-page: 219
  year: 1998
  ident: e_1_2_6_17_1
  article-title: Frequency of late allergy‐like adverse reactions following injection of intravascular non‐ionic contrast media. A retrospective study comparing a non‐ionic monomeric contrast medium with a non‐ionic dimeric contrast medium
  publication-title: Acta Radiol
  contributor:
    fullname: Rydberg J
– ident: e_1_2_6_7_1
  doi: 10.1016/j.ejrad.2008.01.023
– ident: e_1_2_6_20_1
  doi: 10.1067/mhj.2001.113570
– volume: 33
  start-page: 1
  year: 1998
  ident: e_1_2_6_2_1
  article-title: Delayed adverse reactions to non‐ionic monomeric contrast‐enhanced media
  publication-title: Invest Radiol
  doi: 10.1097/00004424-199801000-00001
  contributor:
    fullname: Yasuda R
– ident: e_1_2_6_4_1
  doi: 10.1007/s00330-011-2200-9
– ident: e_1_2_6_8_1
  doi: 10.1177/028418519503600113
– volume: 6
  start-page: 9
  year: 1996
  ident: e_1_2_6_19_1
  article-title: Delayed allergy‐like reactions in patients: monomeric and dimeric contrast media compared with plain CT
  publication-title: Eur Radiol
  contributor:
    fullname: Schild H
SSID ssj0027410
Score 2.101577
Snippet Prospective evaluation of frequency of late and very late adverse events in patients undergoing enhanced or unenhanced magnetic resonance imaging (MRI) or...
Abstract Prospective evaluation of frequency of late and very late adverse events in patients undergoing enhanced or unenhanced magnetic resonance imaging (...
SourceID proquest
crossref
pubmed
pascalfrancis
wiley
SourceType Aggregation Database
Index Database
Publisher
StartPage 427
SubjectTerms Adolescent
Adult
Aged
Aged, 80 and over
Biological and medical sciences
Contrast Media - administration & dosage
Contrast Media - adverse effects
Drug toxicity and drugs side effects treatment
Female
Follow-Up Studies
Humans
Incidence
Magnetic Resonance Imaging - adverse effects
Magnetic Resonance Imaging - methods
Male
Medical sciences
Middle Aged
Miscellaneous (drug allergy, mutagens, teratogens...)
Pharmacology. Drug treatments
Prospective Studies
Surveys and Questionnaires
Time Factors
Tomography, X-Ray Computed - adverse effects
Tomography, X-Ray Computed - methods
Young Adult
Title Late Adverse Events after Enhanced and Unenhanced MRI and CT: A Prospective Study
URI https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fbcpt.12175
https://www.ncbi.nlm.nih.gov/pubmed/24238213
https://www.proquest.com/docview/1513319179
https://search.proquest.com/docview/1520380875
Volume 114
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnZ3fa9swEMeP0r0MxrbuZ7Y2aGz0YdTFllVFHntJ0oRurCMrCfRlGP0yg4ET6uQh--t3J9tJM8age_MP2ZYln_WRffc9gHeZM0LhUBBpnF5FRARRllkVWW15IROnTZDMv_wqL2bi8_XZ9R58bGNhan2IzQc3sozwviYD16a6ZeTGLpakjdCjCHNS0iMiuuK3ZltJEw2JCImc0WiTkhvP9tCd0ejBQlfYMEWd0eJvyLlLsGEIGj-C723la8-Tn6erpTm1v_7Qdfzfu3sMDxs2Zf36YTqAPV8-geNJLW69PmHTbaxWdcKO2WQre71-Ct--ILaykOC58mxEfpQVCynI2aj8ERwNmC4dm5W-Xb28-hQ2DacfWJ9NbuZt3Ccj98b1M5iNR9PhRdQkbIgsgWEkLbeux6WOtbNSCYEjn7AFLxRSQ6KcSXmaJUVihVfKxUZ73G8Ubii4NLFLn8N-OS_9S2BO91zPCusLZCYpjEZURLj1FvlLntmsA2_bjssXtS5H3s5nqO3y0HYd6O706aYoQpVMVIwFDttOzhvjrfKEct7QPBav8mazG82O_qXo0s9XVIbHqaJ0AB14UT8c25MjoiqepB14H7r4HxXMB8PJNCy9ukvh13AfwU3UjpeHsL-8WfkjhKOl6cK9_uB8MO4GY_gN6a4J1A
link.rule.ids 315,786,790,1382,27955,27956,46327,46751
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnZ3bT9swFIetjT1sEhq7ACsw5mkTD4igxHFdhzfWFRVoUUGpxFvkWzRpUlqR9qH763eOk7R0mpC2tyR2brZP_Nk5_h1CviZWcwldQaBgeBUgEQRJYmRglGG5iKzSXjJ_eCP6Y351376vfXNwLUylD7GccEPL8N9rNHCckH5k5dpMZyiO0Gk_Jy_A3ttol9_v2KPxVlSvhwSIBNKo1UnRkWd17lp_tDlVJRRNXsW0-Bt0rjOs74QutqpIq6XXLkTfk5-n85k-Nb_-UHb87_d7Q17XeErPq_b0ljxzxTtyNKr0rRcnNF0t1ypP6BEdrZSvF-_J7QDIlfoYz6WjPXSlLKmPQk57xQ_va0BVYem4cM3u8O7SH-qmZ_Scjh4mzdJPih6Oi20yvuil3X5Qx2wIDLJhIAwztsOECpU1QnIOnR83OcslgEMkrY5ZnER5ZLiT0oZaOUjXEg7kTOjQxjtko5gU7gOhVnVsx3DjcsAmwbUCWgS-dQYQTLRN0iJfmprLppU0R9YMabDsMl92LXK4VqnLrMBVIpIhZDhoajmr7bfMIgx7g0NZuMvnZTJYHv5OUYWbzDEPC2OJEQFaZLdqHauLA6VKFsUtcuzr-IkHzL51R6nf2vuXzJ_Iy346HGSDy5vrffIKOI5XfpgHZGP2MHcfgZVm-tBbxG8sAAyC
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnZ3da9swEMCProMyGFu7rV22ttPo6MOoiy0rilz60qUJ_cYrCfSlGH2ZwcAJdfKQ_fU7yXbSlDHY3mxLtmVJ5_udfboD-JIYxQSqgkCieRU4IgiSRItAS01zHhmpfMj86xt-NmQXd-27FThu1sJU8SHmH9ycZPj3tRPwsckfCbnS44mLjdBpP4PnjMfUmV6nt_SRuRXVyyGRIRE06uCkzo9nce6SOno5liX2TF6ltPgTcy4jrNdB_ddw37S-cj35eTidqEP960lgx_99vHV4VcMpOalm0was2OIN7KdVdOvZARksFmuVB2SfpIu417O38P0KuZX4DM-lJT3nSFkSn4Oc9Iof3tOAyMKQYWGb3evbc3-oOzgiJyR9GDULP4nzb5y9g2G_N-ieBXXGhkA7Mgy4ptp0KJehNJoLxlD1MZ3TXCA2RMKomMZJlEeaWSFMqKTFciXwQE65Ck28CavFqLDvgRjZMR3NtM0RmjhTElkR6dZqBDDe1kkL9pqBy8ZVYI6sMWhc32W-71qwuzSm86pIVTwSIVbYbgY5q6W3zCKX9MYZsniXz_NilDv3M0UWdjR1dWgYC5cPoAVb1eRYXBwZVdAobsFXP8R_aWD2rZsO_NaHf6n8CdbS0352dX5z-RFeIMSxyglzG1YnD1O7g6A0UbteHn4D_ckLMQ
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Late+Adverse+Events+after+Enhanced+and+Unenhanced+MRI+and+CT%3A+A+Prospective+Study&rft.jtitle=Basic+%26+clinical+pharmacology+%26+toxicology&rft.au=Azzouz%2C+Manal&rft.au=R%C3%B8msing%2C+Janne&rft.au=Thomsen%2C+Henrik+S.&rft.date=2014-05-01&rft.issn=1742-7835&rft.eissn=1742-7843&rft.volume=114&rft.issue=5&rft.spage=427&rft.epage=435&rft_id=info:doi/10.1111%2Fbcpt.12175&rft.externalDBID=10.1111%252Fbcpt.12175&rft.externalDocID=BCPT12175
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1742-7835&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1742-7835&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1742-7835&client=summon